Otonomy (OTIC) PT Cut to $32 at Piper Jaffray Post Q2; Maintains 'Overweight'

August 5, 2016 8:24 AM EDT
Get Alerts OTIC Hot Sheet
Price: $16.20 -3.28%

Rating Summary:
    6 Buy, 1 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 35 | Down: 31 | New: 9
Trade OTIC Now!
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Piper Jaffray analyst Joshua Schimmer lowered his price target on Otonomy (NASDAQ: OTIC) to $32.00 (from $42.00) following results after the close but maintained an Overweight rating.

Schimmer commented, "After the close, OTIC reported 2Q16 results and provided an update on the launch of Otiprio for pediatric patients undergoing tympanostomy tube placement (TTP). The company is navigating the hospital P&T committee review process to ensure access and reimbursement and has achieved a high success rate of formulary approval with hundreds of additional hospital reviews scheduled. Multiple upcoming milestones are expected in 2H16 as the company actively pursues expansion opportunities for Otiprio. We reiterate our OW rating."

For an analyst ratings summary and ratings history on Otonomy click here. For more ratings news on Otonomy click here.

Shares of Otonomy closed at $15.22 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT Change

Related Entities

Piper Jaffray, Joshua Schimmer

Add Your Comment